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Abstract 
 
Primary biliary cirrhosis (PBC) is histologically characterized by chronic nonsuppurative 
destructive cholangitis (CNSDC) and the progressive loss of intrahepatic small bile ducts. 
Cellular immune mechanisms involving T cell-reaction are thought to be significantly 
involved in the formation of CNSDC and bile duct loss. In inflammed portal tracts of PBC, 
CD4+ T cells of Th1-type expressing IFN-γ or CXCR3 are aggregated and more commonly 
detected around injured bile ducts than Th2-type CD4+ T cells expressing IL-4 or CCR4, 
indicating that Th1-dominant cellular immunity play a more prominent role in recruitment of 
memory T cell subsets in PBC and may be responsible for the progressive bile duct damage. 
Biliary epithelial apoptosis is demonstrated to be a major pathogenic process of bile duct loss 
in PBC. In CNSDC, several biliary apoptotic cells, an aberrant expression of Fas antigen 
(pro-apoptotic molecule), and decreased expression of bcl-2 and mcl-1 (anti-apoptotic 
molecules) are found, though interlobular bile ducts express bcl-2 and mcl-2, but lack Fas. In 
addition, the up-regulation of WAF1 and p53 related with biliary apoptosis is found in biliary 
epithelial cells of PBC, which may be due to cell senescence in response to genotoxic 
damages such as oxidative stress. Several steps and mechanisms during induction and 
progression of cholangitis and biliary apoptosis followed by bile duct loss are now being 
proposed in PBC, but future analysis of an etiopathogenesis explainable for these 
characteristic histopathogenesis of PBC will be required.  
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Introduction 
Necroinflammatory and fibrous changes and these combinations in parenchyma and 
portal tracts characterize the histology of most hepatobiliary diseases, and the characteristic 
cholangiopathy also take a part in biliary diseases such as primary biliary cirrhosis (PBC) and 
primary sclerosing cholangitis (PSC). PBC primarily affects middle-aged women and is 
characterized by the presence of antimitochondrial antibodies (AMA).1 The initial histology 
of PBC is a distinctive pattern of bile duct damage referred to as chronic nonsuppurative 
destructive cholangitis (CNSDC) and bile duct loss and chronic cholestasis are prominent 
from the early stage.2,3 Non-biliary diseases such as HCV-related chronic hepatitis (CH-C) 
and autoimmune hepatitis (AIH) also often show mild bile duct damage, but the occurrence of 
bile duct loss or cholestasis is very rare. This cholangiopathy found in non-biliary diseases, 
therefore, is denominated as hepatitic duct lesion or hepatitis-associated bile duct injury to 
entirely differ from the cholangiopathy in PBC.4-6 In this review, we describe the molecular 
mechanisms of cholangitis and bile duct loss in PBC. 
 
Histopathology of cholangiopathy in PBC 
The intrahepatic biliary tree is dividable anatomically into large bile ducts, septal bile 
ducts, interlobular bile ducts and bile ductules.7 The morphology and functions of biliary 
epithelial cells are different along the intrahepatic biliary tree. CNSDC usually distribute in 
intrahepatic small bile ducts (interlobular bile ducts and septal bile ducts), but bile duct loss 
progresses mainly in the level of interlobular bile ducts. Biliary epithelial cells consisting 
CNSDC show the proliferative change such as papillary and stratified ingrowths with high 
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cell kinetic activity, and simultaneously the destructive change such as eosinophilic and 
swollen degeneration.2,8,9 Chronic inflammatory cells including lymphocytes and plasma cells 
infiltrate around the injured bile ducts in PBC, and eosinophils and macrophages are also 
noted in several portal tracts. A focal aggregate of epithelioid cells, sometimes forming 
well-developed granuloma, is present and surrounds the CNSDC (granulomatous cholangitis) 
(Fig.1). These injured bile ducts finally disappear by the mechanism of enhanced biliary 
apoptosis from the early stage of PBC (see below). Significant bile duct loss refers to the 
condition in which more than 50% of the portal tracts which lack these bile ducts in liver 
specimens, though peripheral portal tracts constantly contain well-formed interlobular or 
septal bile ducts in addition to portal vein and hepatic arterial branches in normal livers.2,10 
Hepatitis-associated changes in parenchyma such as necroinflammatory changes, Kupffer cell 
hyperplasia, and intrasinusoidal lymphocytic infiltration are generally mild in PBC. However, 
the characteristic findings of copper deposition and liver cell dysplasia suggesting chronic 
cholestatic conditions are prominent from the early stages and very useful for pathological 
diagnosis of PBC. Especially, copper deposition is a sensitive finding suggesting the presence 
of chronic cholestasis and orcein staining (Shikata’s orcein) is the most useful staining for 
evaluating copper-associated proteins. 
 
Cytokines and chemokines around bile ducts in PBC 
Cell population within and around bile ducts in PBC 
Cytokines produced by lymphocytes infiltrating around CNSDC, are closely associated 
with the progression of bile duct injury in PBC, because biliary epithelial cells bear several 
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cytokine receptors against at least IL-4, IL-6, IFN-γ, and TNF-α (type2-TNF receptor).11 In 
addition, biliary epithelial cells themselves also produce TNF-α and IL-6, so these cytokines 
affect themselves in autocrine and paracrine matters.12 In PBC, it is generally believed that T 
cell-related cellular immunity is involved in the pathogenesis of CNSDC. Indeed, it has been 
demonstrated that CD8+ and CD4+ lymphocytes are the predominant cell type in the 
inflammatory cells within portal tracts in PBC.13,14 CD8+ lymphocytes are mostly cytotoxic T 
cells and affect the targets via the perforin/granzyme exocytosis pathway.15,16 CD4+ 
lymphocytes, especially pathogenic autoreactive T cells, regulate the autoimmunity around 
bile ducts in PBC. Moreover, in the development of cholangiopathy, the infiltration of 
immune cells within the biliary epithelial layer and the direct adhesion between biliary 
epithelial cells and immune cells are key events leading to cell-mediated cytotoxicity and 
apoptosis of biliary epithelial cells.15,16 The finding of lymphocytic recruitment around the 
bile ducts and of penetration into the biliary layer is termed as an ‘epitheliotropism’, which is 
associated with the increased cellular permeability of bile ducts caused by significant 
reduction of tight junction molecules in PBC.17-19 This epitheliotropism is found in normal 
livers as well as PBC livers. In normal livers, intra-epithelial lymphocytes existing in 
interlobular bile ducts are mainly CD8+ lymphocytes and though to be involved in the 
immune homeostasis of intrahepatic bile ducts.20 
Cytokine milieu around bile ducts in PBC 
A number of (pro)inflammatory cytokines are known to be elevated in the local portal tract 
microenvironment in PBC, contributing to development of chronic inflammatory reaction 
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around bile ducts and biliary epithelial cells as well as immune cells actively participate in 
this inflammatory process. Immunoreactivity and autoimmunity are regulated by two different 
types of CD4+ helper T cells, Th1 and Th2 subsets, principally subdivided by distinctive 
cytokine production and effector functions. Th1 cells involved in the cell mediated response, 
provide help to cytotoxic CD8+ T lymphocytes, activate natural killer cells, and produce 
delayed hypersensitivity reactions. Th1 clones secrete IL-2, IFN-γ and TNF-β. In contrast, 
Th2 cells involved in the humoral response is characterized by the differentiation and 
activation of B cells into antibody secreting plasma cells. Th2 clones secrete IL-4, IL-5, IL-6, 
IL-10 and IL-13. A polarized cytokine profile plays a pivotal role as a pathophysiological 
factor in autoimmunity; organ-specific autoimmune diseases are mainly mediated by Th1 
cells, while in systemic autoimmune disorders Th2 subset predominates. In PBC, the presence 
of a predominant Th1 cytokine profile is demonstrated.21 Cytokine profiles determined 
primarily from stimulated peripheral blood and liver-derived T lymphocytes may be 
misleading for defining a Th1/Th2 cytokine profile in PBC.22,23 In situ hybridization study 
reveals that IFN-γ mRNA-expressing mononuclear cells are more commonly detected 
primarily around damaged bile ducts in PBC livers than IL-4 mRNA-expressing cells and that 
levels of IFN-γ mRNA expression are highly correlated with the degree of portal 
inflammatory activity (Fig.2).24 Cytokine levels in sera and whole liver may not accurately 
reflect local hepatic tissue levels, because cytokines primarily have a local or paracrine mode 
of action. However, the analyses of cytokine synthesis using peripheral blood mononuclear 
cells and whole livers also reveal that a slight elevation of Th1 prevalence, as well as a 
significant decline of Th2 prevalence, is observed in PBC.25,26  
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Recent study has reported that CD8+ and CD4+ (in particular CD4+ CD28-) are markedly 
increased as intra-epithelial lymphocytes within damaged bile ducts in PBC.20 Because these 
unique CD4+CD28- T cells proliferate in target tissue of autoimmune diseases and are 
associated with Th1/Th2 balance in the regulation of spontaneous autoimmune diseases by 
possessing the high expression of IFN-γ and autoreactive and cytolytic function, CD4+CD28- 
T cells may be involved in the pathogenesis of autoimmune-mediated bile duct damage of 
PBC.27,28 
Chemokine milieu around bile ducts in PBC 
Continued recruitment of pathogenic lymphocytes including autoreactive T cells 
contributes to the progressive bile duct destruction in PBC. Chemokines (chemotactic 
lymphokines) have well-defined roles in the regulation of leukocyte recruitment and retention, 
and positioning in tissues. Fractalkine (CX3CL1) consisting of a membrane-bound form and a 
soluble chemotactic form, is produced by several epithelial cells and associated with the 
cell-adhesion and the chemoattractant for its receptor (CX3CR1)-expressing cells such as 
CD8+ and CD4+ T cells.29,30 The production of fractalkine is demonstrated in biliary epithelial 
cells and upregulated by several cytokines including IFN-γ and TNF-α. In PBC, the 
expression of fractalkine is upregulated in injured bile ducts of PBC and the CD4+ and CD8+ 
lymphocytes expressing CX3CR1 are found in portal tracts and within biliary epithelial layer 
of injured bile ducts. 
The preferential association of some chemokine receptors with Th1 or Th2 cells has been 
reported, providing a basis for tissue-specific recruitment of memory T cell subsets. CXCR3 
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and CCR5 are expressed at higher levels on Th1 cells.31,32 In contrast, CCR3 and CCR4 are 
found on Th2 cells.31 At early stage of PBC, the mononuclear cells positive for CXCR3 (Th1) 
are dense around the damaged bile ducts and the ratio of CXCR3-/CCR4-positive 
mononuclear cells (Th1/Th2) in portal tracts of early PBC is significantly higher than that of 
advanced PBC.33 In addition, the expression of IFN-γ-inducible protein-10 (IP-10, CXCL10) 
and monokine induced by IFN-γ (MIG, CXCL9) is increased in plasma and portal tracts in 
PBC, which chemokines are synthesized predominantly by macrophages following exposure 
to IFN-γ and involved in the selective recruitment of Th1 cells via CXCR3.34 These data also 
suggest that the enhanced shift toward Th1 occurs in portal tracts of PBC 
 
Mechanism of bile duct loss in PBC 
Apoptosis of biliary epithelial cells 
Apoptosis (programmed cell death) conventionally has been defined as nuclear 
condensation and fragmentation by electron microscopy (Fig.3). Recent molecular analysis 
revealed that apoptosis is biochemically characterized by DNA fragmentation caused by the 
activation of endonuclease as a final event and constitutes a strictly regulated mechanism for 
the removal of unnecessary, aged or damaged cells. In addition, apoptosis plays an essential 
role in the pathogenesis and the development of many human diseases including autoimmune 
diseases as well as in physiological condition. Light-microscopically, apoptotic cells of biliary 
epithelial cells are characterized by shrinkage of cytoplasm and condensation of nucleus and 
scatter in intrahepatic biliary tree in physiological conditions (Fig.3). Approximately 4% 
apoptotic cells are found in the large bile ducts and septal bile ducts, whereas very rare in 
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interlobular bile ducts (below 1%).35 This suggests that the cell kinetics of biliary epithelial 
cells with respect to apoptosis differs according to the anatomical level of the biliary tree. 
That is, the loss and renewal of biliary epithelial cells occur relatively rapidly in the large and 
septal bile ducts compared with the interlobular bile ducts. The type and/or amounts of 
physiologic stimuli responsible for the induction of apoptosis may vary along the biliary tree 
and be a cause of the different homeostasis (cell death-renewal mechanism) of intrahepatic 
bile ducts. Morphological recognition of biliary epithelial apoptosis may underestimate the 
real rate of apoptosis, because apoptotic biliary epithelial cells are probably rapidly shed into 
bile and eliminated from the biliary tree without histologic recognition. In recent studies, 
terminal deoxynucleotidly transferase (TdT)-mediated deoxyuridine triphosphate 
(dUTP)-nick end labeling (TUNEL) is used in practice as a method to identify apoptotic cells 
in situ. Conventional and morphological apoptotic biliary cells certainly show the 
TUNEL-positivity, and some biliary cells lacking morphological apoptosis are also positive 
for TUNEL staining. In PBC, TUNEL-positive apoptotic cells are frequently found on biliary 
epithelial cells, particularly more cholangitic bile ducts.  
Apoptosis-related molecules in biliary epithelial cells 
The process of apoptosis can be subdivided into three phases: initiation, effector and 
degradation. The initiation stage of apoptosis depends on the type of apoptosis-inducing 
stimulus, but the effector and degradation stages are common to all apoptotic processes. In 
biliary epithelial cells, several apoptosis-related molecules including Bcl-2-family, Fas-Fas 
ligand, and WAF-1, act in the initiation stage.9,35-40 The regulatory mechanisms of biliary 
                           HARADA - 10 - 
apoptosis are different according to the anatomical location of the intrahepatic biliary tree 
depending the expression of these apoptosis-related molecules.35 
Bcl-2-family proteins are resident proteins of the mitochondrial membrane and share 
several highly conserved regions and interact with one another through the formation of 
homo- and heterodimers. The susceptibility of cells to apoptotic stimuli is thought to be 
controlled by the relative ratios of these different Bcl-2 family proteins.41  Bcl-2 and Mcl-1 
(both anti-apoptotic) prevent cells from undergoing apoptosis when overexpressed, whereas 
Bax (pro-apoptotic) functions to promote apoptosis. Bcl-X is subdivided to Bcl-XL (long) and 
Bcl-XS (short) through the alternative RNA splicing of Bcl-X gene, which are anti-apoptotic 
and pro-apoptotic, respectively.42 Overexpression of Bax functions to promote cell death via 
apoptosis through the formation of Bax homodimers41 and to release cytochrome C (an 
apoptosis-inducing factor) from mitochondria to cytosol. This release is known to lead to an 
activation of caspase 9 and subsequently caspase 3. However, the formation of heterodimers 
between Bax and Bcl-2 homologues with death repressor function (Bcl-2, Mcl-1 and Bcl-XL, 
especially Bcl-2) leads to inhibition of the death promoting effects of Bax.41 In liver, the 
expression of Bcl-2 is restricted in the interlobular bile ducts and bile ductules, but not 
detectable in the large and septal bile ducts and hepatocytes.43 In contrast, Bcl-XL and Mcl-1 
(anti-apoptotic) and Bax (pro-apoptotic) are diffusely expressed in the intrahepatic biliary 
tree.35 Therefore, the ratio of Bax vs Bcl-2 is higher in the large and septal bile ducts than in 
the interlobular bile ducts and bile ductules, and is responsible for the unique distribution of 
conventional apoptotic biliary cells along the intrahepatic biliary tree in normal conditions as 
described above.35  
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Fas receptor, also known as APO-1 or CD95, belongs to TNF superfamily and has the 
intracellular death domain. Fas activation causes a complex sequence of events, which finally 
leads to Fas membrane targeting and formation of the death-inducing signalings complexes 
(DISC), that is, the recruitment of the Fas-associated death domain (FADD) and procaspase 8 
to the Fas. Fas ligand is also a cell surface molecule on the effector cells including cytotoxic T 
cells, natural killer cells and the Th1 subset of T helper cells; Fas ligand induces apoptosis in 
target cells by triggering Fas in susceptible target cells. In liver, Fas antigen plays an 
important role in liver homeostasis, because hepatocytes constantly express Fas on their 
cellular membrane and are exquisitely sensitive to apoptosis mediated by Fas-Fas ligand 
signaling. Biliary epithelial cells also express Fas antigen, but the distribution of Fas shows 
heterogeneity in the intrahepatic biliary tree. Fas expression is observed in the large bile ducts, 
but rarely in the interlobular bile ducts and bile ductules. In the septal bile ducts, its 
expression is intermediate, and positive and negative biliary cells often mingled in the same 
ducts.35 This suggests that biliary epithelial cells consisting of large bile ducts are also 
sensitive to Fas-mediated apoptosis and supports that the number of conventional apoptosis is 
relatively larger in biliary epithelial cells of the large bile ducts than those of interlobular bile 
ducts as mentioned above. Among caspase cascades, caspase 3, caspase 8, and caspase 9 play 
a pivotal role in the intracellular signaling of Fas-mediated apoptosis; Fas activation induces 
the cleavage of caspase 8 followed by directly or indirectly the cleavage of caspase 3. Biliary 
epithelial cells constantly express caspase 3, caspase 8, and caspase 9, but the intracellular 
signaling pathway leading apoptosis in biliary epithelial cells is entirely unknown. 
Cell senescence of biliary epithelial cells is also noted as a process of apoptosis.40 
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Replicative cell senescence caused by replication and/or by diverse agents such as oxidative 
stress and bile acids, and other detergent substances in the bile (“bad bile”), may be related to 
the induction of DNA damage and apoptosis of biliary epithelial cells.19,44-47 WAF1 
(p21WAF1/Cip1) is a potent and reversible inhibitor of cell-cycle progression at both the G1 and 
G2 checkpoint and an important molecule of cell-cycle regulation and homeostasis. 
p53-dependent WAF1 up-regulation followed by irreversible G1 arrest is one of major 
mechanism to delete the genetical damaged cells in carcinogenesis and cellular senescence of 
biliary epithelial cells. 
40,48,49 
Enhanced biliary apoptosis in PBC  
 TUNEL-positive apoptotic cells are frequently found on biliary epithelial cells, 
particularly more cholangitic bile ducts in PBC, but very a few in control livers (Fig.4). These 
biliary epithelial cells showing cholangitis aberrantly express Fas antigen in their luminal 
surface and/or basolateral membrane accompanying the infiltration of Fas ligand-expressing 
inflammatory cells.16,35,37 Because TNF-α and IFN-γ have been shown to induce an increase 
in Fas receptor expression and enhance anti-Fas-induced apoptosis, these cytokines may 
involved in the occurrence of apoptotic cell death on damaged bile ducts in PBC through this 
system. The bcl-2 family reportedly is also associated with the biliary epithelial apoptosis in 
PBC.38,50 Among bcl-2 family, the downregulation of bcl-2, mcl-1, and bcl-XL leads to a 
decrease in the threshold of apoptosis and increases in the vulnerability to apoptotic stimuli in 
the damaged bile ducts, followed by the progressive bile duct loss in PBC.9,36,37,51 Celli et al., 
have demonstrated that using a human biliary epithelial cell line the reduction in the cellular 
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levels of an antioxidant cytoprotective molecules such as glutathione results in increased 
degradation of bcl-2 protein and an increase in biliary epithelial apoptosis.52 By the close 
examination of Fas and bcl-2 expression in interlobular bile ducts, we have confirmed that 
Fas-positive and bcl-2-negative bile ducts are very specific for PBC livers, suggesting the 
increased susceptibility for apoptotic signals in biliary epithelial cells of PBC (Fig.5). In 
addition, the up-regulation of WAF1 and p53 is found in biliary epithelial cells and relates to 
the biliary apoptosis in cholangitis of PBC, which may be due to cell senescence of biliary 
epithelial cells in response to genotoxic damages such as oxidative stress.40  
In addition, infectious agents including bacteria and virus are suspected of being involved 
in the etiopathogenesis of PBC and/or the pathogenesis of bile duct damage in PBC. 
Mycobacterium, Escherichia coli (E.coli), Propionibacterium acnes (P.acnes), Lactobacillus, 
and retrovirus have been reported as possible candidates based on serological examinations or 
on molecular analysis.53-59 Although it is a matter of controversy whether these 
microorganisms are directly or indirectly causative pathogens of PBC or not, infectious agents 
may increase the susceptibility for apoptosis in biliary epithelial cells. 
 
Conclusions 
Th1 cytokines including IFN-γ predominate over Th2 in PBC livers and enhanced biliary 
apoptosis is responsible for the progressive bile duct loss in PBC. However, the mechanisms 
for such dysregulation of cytokine milieu and apoptosis-related molecules in biliary epithelial 
cells are unknown. In view of recent reports of possible microorganisms involvement in the 
multi-factorial process that leads to the development of PBC, further studies are needed to 
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address this issue. 
                           HARADA - 15 - 
References 
1. Kaplan MM (1996) Primary biliary cirrhosis. N Engl J Med 335: 1570-1580. 
2. Nakanuma Y, Ohta G (1979) Histometric and serial section observations of the 
intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 76: 1326-1332. 
3. Ludwig J, Dickson ER, McDonald GS (1978) Staging of chronic nonsuppurative 
destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol 
Anat Histol 379: 103-112. 
4. Goodman ZD, Ishak KG (1995) Histopathology of hepatitis C virus infection. Semin 
Liver Dis 15: 70-81. 
5. Sato Y, Harada K, Sudo Y, Watanabe K, Nakahama T, Morimoto H, Nakanuma Y (2002) 
Autoimmune hepatitis associated with bile duct injury resembling chronic 
non-suppurative destructive cholangitis. Pathol Int 52: 478-482. 
6. Zen Y, Harada K, Sasaki M, Tsuneyama K, Matsui K, Haratake J, Sakisaka S, et al. 
(2005) Are bile duct lesions of primary biliary cirrhosis distinguishable from those of 
autoimmune hepatitis and chronic viral hepatitis? Interobserver histological agreement on 
trimmed bile ducts. J Gastroenterol 40: 164-170. 
7. Nakanuma Y, Hoso M, Sanzen T, Sasaki M (1997) Microstructure and development of 
the normal and pathologic biliary tract in humans, including blood supply. Microsc Res 
Tech 38: 552-570. 
8. Nakanuma Y, Harada K (1993) Florid duct lesion in primary biliary cirrhosis shows 
highly proliferative activities. J Hepatol 19: 216-221. 
9. Graham AM, Dollinger MM, Howie SE, Harrison DJ (1998) Bile duct cells in primary 
biliary cirrhosis are 'primed' for apoptosis. Eur J Gastroenterol Hepatol 10: 553-557. 
10. Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RA (1987) The acute vanishing bile 
duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. 
Hepatology 7: 476-483. 
11. Harada K, Isse K, Nakanuma Y (2006) Interferon gamma accelerates NF-kappaB 
activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction. J 
Clin Pathol 59: 184-190. 
12. Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y (1998) 
Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic 
biliary epithelial cells: in situ and culture study. Lab Invest 78: 89-100. 
                           HARADA - 16 - 
13. van den Oord JJ, Fevery J, de Groote J, Desmet VJ (1984) Immunohistochemical 
characterization of inflammatory infiltrates in primary biliary cirrhosis. Liver 4: 264-274. 
14. Krams SM, Van de Water J, Coppel RL, Esquivel C, Roberts J, Ansari A, Gershwin ME 
(1990) Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with 
primary biliary cirrhosis. Hepatology 12: 306-313. 
15. Yamada G, Hyodo I, Tobe K, Mizuno M, Nishihara T, Kobayashi T, Nagashima H (1986) 
Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct 
epithelia in primary biliary cirrhosis. Hepatology 6: 385-391. 
16. Harada K, Ozaki S, Gershwin ME, Nakanuma Y (1997) Enhanced apoptosis relates to 
bile duct loss in primary biliary cirrhosis. Hepatology 26: 1399-1405. 
17. Yasoshima M, Tsuneyama K, Harada K, Sasaki M, Gershwin ME, Nakanuma Y (2000) 
Immunohistochemical analysis of cell-matrix adhesion molecules and their ligands in the 
portal tracts of primary biliary cirrhosis. J Pathol 190: 93-99. 
18. Sakisaka S, Kawaguchi T, Taniguchi E, Hanada S, Sasatomi K, Koga H, Harada M, et al. 
(2001) Alterations in tight junctions differ between primary biliary cirrhosis and primary 
sclerosing cholangitis. Hepatology 33: 1460-1468. 
19. Sakisaka S, Koga H, Sasatomi K, Mimura Y, Kawaguchi T, Tanikawa K (1997) Biliary 
secretion of endotoxin and pathogenesis of primary biliary cirrhosis. Yale J Biol Med 70: 
403-408. 
20. Isse K, Harada K, Sato Y, Nakanuma Y (2006) Characterization of biliary intra-epithelial 
lymphocytes at different anatomical levels of intrahepatic bile ducts under normal and 
pathological conditions: numbers of CD4+CD28- intra-epithelial lymphocytes are 
increased in primary biliary cirrhosis. Pathol Int 56: 17-24. 
21. Berg PA, Klein R, Rocken M (1997) Cytokines in primary biliary cirrhosis. Semin Liver 
Dis 17: 115-123. 
22. Martinez OM, Villanueva JC, Gershwin ME, Krams SM (1995) Cytokine patterns and 
cytotoxic mediators in primary biliary cirrhosis. Hepatology 21: 113-119. 
23. Lohr HF, Schlaak JF, Gerken G, Fleischer B, Dienes HP, Meyer zum Buschenfelde KH 
(1994) Phenotypical analysis and cytokine release of liver-infiltrating and peripheral 
blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 14: 
161-166. 
24. Harada K, Van de Water J, Leung PS, Coppel RL, Ansari A, Nakanuma Y, Gershwin ME 
                           HARADA - 17 - 
(1997) In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: 
predominance of the Th1 subset. Hepatology 25: 791-796. 
25. Sekiya H, Komatsu T, Isono E, Furukawa M, Matsushima S, Yamaguchi N, Yamauchi K, 
et al. (1999) Decrease in the prevalence of IL-4-producing CD4+ T cells in patients with 
advanced stage of primary biliary cirrhosis. Am J Gastroenterol 94: 3589-3594. 
26. Nagano T, Yamamoto K, Matsumoto S, Okamoto R, Tagashira M, Ibuki N, Matsumura S, 
et al. (1999) Cytokine profile in the liver of primary biliary cirrhosis. J Clin Immunol 19: 
422-427. 
27. Kamihira T, Shimoda S, Harada K, Kawano A, Handa M, Baba E, Tsuneyama K, et al. 
(2003) Distinct costimulation dependent and independent autoreactive T-cell clones in 
primary biliary cirrhosis. Gastroenterology 125: 1379-1387. 
28. Lenschow DJ, Herold KC, Rhee L, Patel B, Koons A, Qin HY, Fuchs E, et al. (1996) 
CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. 
Immunity 5: 285-293. 
29. Muehlhoefer A, Saubermann LJ, Gu X, Luedtke-Heckenkamp K, Xavier R, Blumberg RS, 
Podolsky DK, et al. (2000) Fractalkine is an epithelial and endothelial cell-derived 
chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol 
164: 3368-3376. 
30. Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, Imai T, Patel DD (1998) 
Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, 
and activation under physiologic flow. J Exp Med 188: 1413-1419. 
31. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A (1998) Flexible programs of 
chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp 
Med 187: 875-883. 
32. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, et al. 
(1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated 
with certain inflammatory reactions. J Clin Invest 101: 746-754. 
33. Harada K, Tsuneyama K, Yasoshima M, Kanemori Y, Ohta H, Masuda S, Onai N, et al. 
(2002) Type1 and type2 memory T cells imbalance shown by expression of intrahepatic 
chemokine receptors relates to pathogenesis of primary biliary cirrhosis. Hepatol Res 24: 
290-299. 
34. Chuang YH, Lian ZX, Cheng CM, Lan RY, Yang GX, Moritoki Y, Chiang BL, et al. 
                           HARADA - 18 - 
(2005) Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG 
in patients with primary biliary cirrhosis and their first degree relatives. J Autoimmun 25: 
126-132. 
35. Harada K, Iwata M, Kono N, Koda W, Shimonishi T, Nakanuma Y (2000) Distribution of 
apoptotic cells and expression of apoptosis-related proteins along the intrahepatic biliary 
tree in normal and non-biliary diseased liver. Histopathology 37: 347-354. 
36. Iwata M, Harada K, Kono N, Kaneko S, Kobayashi K, Nakanuma Y (2000) Expression of 
Bcl-2 familial proteins is reduced in small bile duct lesions of primary biliary cirrhosis. 
Hum Pathol 31: 179-184. 
37. Kuroki T, Seki S, Kawakita N, Nakatani K, Hisa T, Kitada T, Sakaguchi H (1996) 
Expression of antigens related to apoptosis and cell proliferation in chronic 
nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch 429: 
119-129. 
38. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K (1997) Nuclear DNA fragmentation 
and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 25: 1077-1084. 
39. Dienes HP, Lohse AW, Gerken G, Schirmacher P, Gallati H, Lohr HF, Meyer zum 
Buschenfelde KH (1997) Bile duct epithelia as target cells in primary biliary cirrhosis and 
primary sclerosing cholangitis. Virchows Arch 431: 119-124. 
40. Harada K, Furubo S, Ozaki S, Hiramatsu K, Sudo Y, Nakanuma Y (2001) Increased 
expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to 
apoptosis. J Hepatol 34: 500-506. 
41. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6. 
42. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, et al. 
(1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell 
death. Cell 74: 597-608. 
43. Charlotte F, L'Hermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, Zafrani ES (1994) 
Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. 
Am J Pathol 144: 460-465. 
44. Celli A, Que FG (1998) Dysregulation of apoptosis in the cholangiopathies and 
cholangiocarcinoma. Semin Liver Dis 18: 177-185. 
45. Reinehr R, Becker S, Keitel V, Eberle A, Grether-Beck S, Haussinger D (2005) Bile 
salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology 
                           HARADA - 19 - 
129: 2009-2031. 
46. Sasatomi K, Noguchi K, Sakisaka S, Sata M, Tanikawa K (1998) Abnormal accumulation 
of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing 
cholangitis. J Hepatol 29: 409-416. 
47. Koga H, Sakisaka S, Yoshitake M, Harada M, Kumemura H, Hanada S, Taniguchi E, et al. 
(2002) Abnormal accumulation in lipopolysaccharide in biliary epithelial cells of rats 
with self-filling blind loop. Int J Mol Med 9: 621-626. 
48. Lunz JG, 3rd, Contrucci S, Ruppert K, Murase N, Fung JJ, Starzl TE, Demetris AJ (2001) 
Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver 
allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the 
influence of immunosuppressive drugs. Am J Pathol 158: 1379-1390. 
49. el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, 
Pietenpol JA, et al. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and 
apoptosis. Cancer Res 54: 1169-1174. 
50. Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A (2001) Bcl-2-dependent 
oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during 
apoptosis. J Clin Invest 108: 223-232. 
51. Tinmouth J, Lee M, Wanless IR, Tsui FW, Inman R, Heathcote EJ (2002) Apoptosis of 
biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. 
Liver 22: 228-234. 
52. Celli A, Que FG, Gores GJ, LaRusso NF (1998) Glutathione depletion is associated with 
decreased Bcl-2 expression and increased apoptosis in cholangiocytes. Am J Physiol 275: 
G749-757. 
53. Harada K, Tsuneyama K, Sudo Y, Masuda S, Nakanuma Y (2001) Molecular 
identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary 
cirrhosis: is Propionibacterium acnes involved in granuloma formation? Hepatology 33: 
530-536. 
54. Klein R, Wiebel M, Engelhart S, Berg PA (1993) Sera from patients with tuberculosis 
recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary 
biliary cirrhosis. Clin Exp Immunol 92: 308-316. 
55. Vilagut L, Vila J, Vinas O, Pares A, Gines A, Jimenez de Anta MT, Rodes J (1994) 
Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major 
                           HARADA - 20 - 
mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol 21: 673-677. 
56. Butler P, Valle F, Hamilton-Miller JM, Brumfitt W, Baum H, Burroughs AK (1993) M2 
mitochondrial antibodies and urinary rough mutant bacteria in patients with primary 
biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol 17: 408-414. 
57. Hiramatsu K, Harada K, Tsuneyama K, Sasaki M, Fujita S, Hashimoto T, Kaneko S, et al. 
(2000) Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene 
in gallbladder bile from patients with primary biliary cirrhosis. J Hepatol 33: 9-18. 
58. Bogdanos DP, Baum H, Okamoto M, Montalto P, Sharma UC, Rigopoulou EI, 
Vlachogiannakos J, et al. (2005) Primary biliary cirrhosis is characterized by IgG3 
antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus 
mimic. Hepatology 42: 458-465. 
59. Xu L, Sakalian M, Shen Z, Loss G, Neuberger J, Mason A (2004) Cloning the human 




                           HARADA - 21 - 
Figures and figure legends 
 
Fig 1  Granulomatous cholangitis in primary biliary cirrhosis. Chronic non-suppurative 
destruction cholangitis accompanying well-developed epithelioid cell granuloma (Gra) 
is referred as granulomatous cholangitis. (HE staining, Original magnification, x100) 
 
 
Fig 2  IFN-γ-mRNA expressing mononuclear cells around and within injured bile ducts in 
primary biliary cirrhosis (arrows). (In situ hybridization for IFN-γ mRNA, Original 
magnification, x200) 
 
                           HARADA - 22 - 
 
Fig 3  Interlobular bile ducts in normal liver (A) and injured bile ducts in PBC (B). 
Apoptosis of biliary epithelial cells are characterized morphologically by 
cytoplasmic shrinkage and nuclear condensation (arrows). (HE staining, original 
magnification x200 (A) and x400 (B)) 
 
 
Fig 4  Primary biliary cirrhosis. Conventional apoptotic cells (arrows) certainly show the 
TUNEL-positivity. (Terminal deoxynucleotidly transferase-mediated deoxyuridine 
triphosphate-biotin nick end labeling staining, Original magnification, x200). 
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Fig 5  Primary biliary cirrhosis. (A) Injured bile ducts show definite membranous staining 
for Fas. (B) Injured bile ducts (arrows) are completely negative for Bcl-2, though 
infiltrating mononuclear cells are positive. (Immunohistochemical staining for Fas 
(A) and Bcl-2 (B) counterstained with hematoxylin. Original magnification, x200) 
 





